id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0139-0007,FDA,FDA-2011-E-0139,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:00:15Z,,0,0,090000648119d08b
FDA-2011-E-0139-0006,FDA,FDA-2011-E-0139,Regulatory Review Period for Purposes of Patent Extension: EQUIDONE GEL,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-04T13:44:26Z,2012-10853,0,0,0900006481005021
FDA-2011-E-0139-0005,FDA,FDA-2011-E-0139,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T12:50:34Z,,0,0,0900006480ff338b
FDA-2011-E-0139-0004,FDA,FDA-2011-E-0139,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T14:25:51Z,,0,0,0900006480f91f09